Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_02818 |
| Species: | Homo sapiens |
| Position : | chr3:30300000-31100000 |
| Year: | 2024 |
| Title: | Enhancer-promoter hubs organize transcriptional networks promoting oncogenesis and drug resistance. |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| PMID: | 39277592 |
| Tissue: | blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | iPSC-derived erythroblasts |
| Cell Type: | iPSC-derived erythroblast |
| Experiment Type: | Chromatin interaction assay, Functional perturbation assay |
| High Throughput Method: | Hi-C; ATAC-seq; H3K27ac ChIP-seq; RNA-seq |
| Low Throughput Method: | RT-RT-qPCR |
| Target gene : | PTPRG |
| TF name : | NA |
| Regulatory State : | Repressed |
| GeneName | Pathway Name | Source | Gene Number |
|---|